OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing
PR96091
OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time
SAN JOSE, Calif., May 24, 2022 /PRNewswire=KYODO JBN/ --
OptraSCAN(R) [https://www.optrascan.com/], the leading end-to-end digital
pathology solution provider, announced its digital pathology scanner OS-SiA has
been granted US patent - No 2020/0334814 A1 by the United States Patent and
Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze
pathological samples simultaneously. This will benefit the end-user to view the
whole slide scanned image along with analyzed output as an overlay during their
review process.
The patent describes a technique invented by OptraSCAN, the AI-enabled
digital pathology scanner OS-SiA
[https://www.optrascan.com/products/os-sia-ai-enabled-scanner] automatically
identifies specimens to scan and simultaneously analyzes the tissue or cell
area being scanned. OS-SiA is the industry's first AI-enabled digital scanner
that will provide real-time predictive analysis and actionable insights.
"Currently, the digital pathology slide scanners are restricted to partial
or whole slide image acquisition and digitization into an image. Our
next-generation scanner OS-SiA scans and analyzes simultaneously eliminating
the need for additional processing applications," said Abhi Gholap, Founder &
CEO, OptraSCAN. "This patent highlights our constant efforts to improve the
adoption of digital pathology solutions and support the pathology community."
OS-SiA can be embedded in the existing series of its cloud-enabled
brightfield scanners namely OS-Lite & OS-Ultra. The custom algorithms provide
real-time ROI detection while scanning, cell quantification for IHC/HNE
markers, and morphological measurements built using the core library. The whole
slide image can be viewed in a local / web-based / cloud-based image viewer.
The deep learning computational module is provided for self-learning in the
scanning device.
"This is the kind of breakthrough we need to accelerate the adoption of
digital pathology, simultaneous scanning and analysis will help pathologists
make faster decisions and improve patient outcomes." Dr. Zu-Hua Gao MD, Medic
About OptraSCAN, Inc:
OptraSCAN(R) [https://www.optrascan.com/] are pioneers in the On-Demand
Digital Pathology(R) System, focused on delivering fully integrated, affordable
solutions that will maximize your return on investment and improve the
performance of your pathology services. An ISO 13485 certified company and CE
marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the
barriers to 'Go Digital' no matter the size of the pathology lab, the lab's
throughput, or global location.
OptraSCAN's end-to-end digital pathology solution provides effective
acquisition of whole slide images, viewing, storing, real-time sharing,
reporting and AI & ML based Image analysis solutions via On-Demand or outright
purchase model. Follow Us on LinkedIn
[https://in.linkedin.com/company/optra-scan] and Twitter
[https://mobile.twitter.com/optrascan].
Photo: https://mma.prnewswire.com/media/1820629/OS_SIA_final.jpg
Logo: https://mma.prnewswire.com/media/1517923/Optra_Scan_Logo.jpg
Source: OptraSCAN Inc.
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。